Detection of EBV in nasopharyngeal carcinoma by quantum dot fluorescent in situ hybridization

Experimental and Molecular Pathology

Volumn 89, Issue 3, 2010, Pages 367-371

  Chen, Hong lei ^a   Peng, Jun ^a   Zhu, Xiao bo ^b   Gao, Jun ^a   Xue, Jing ling ^a   Wang, Ming wei ^c   Xia, He shun ^c  

^a WUHAN UNIVERSITY   (China)

^b Wuhan Tumor Nanometer Diagnosis Engineering Research Center   (China)

^c HUBEI CANCER HOSPITAL   (China)

Author keywords

Epstein Barr virus encoded RNA; Fluorescent in situ hybridization; In situ hybridization; Nasopharyngeal carcinoma; Quantum dots

Indexed keywords

PARAFFIN; QUANTUM DOT; STREPTAVIDIN; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPHOCYTIC INFILTRATION; NASOPHARYNX CARCINOMA; NONHUMAN; OLIGONUCLEOTIDE PROBE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SOUTHEAST ASIA; UNDIFFERENTIATED CARCINOMA; VIRUS DETECTION;

CARCINOMA; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; IN SITU HYBRIDIZATION, FLUORESCENCE; NASOPHARYNGEAL NEOPLASMS; QUANTUM DOTS; REPRODUCIBILITY OF RESULTS; RNA, VIRAL;

HUMAN HERPESVIRUS 4;

EID: 78249237192     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.09.004     Document Type: Article

References (24)

1. Bentolila L.A., Weiss S. Single-step multicolor fluorescence in situ hybridization using semiconductor quantum dot-DNA conjugates. Cell Biochem. Biophys. 2006, 45:59-70.
2. Brousset P., Butet V., Chittal S., Selves J., Delsol G. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody. Lab. Invest. 1992, 67:457-464.
3. Byers R.J., Di Vizio D., O'connell F., Tholouli E., Levenson R.M., Gossage K., Twomey D., Yang Y., Benedettini E., Rose J., Ligon K.L., Finn S.P., Golub T.R., Loda M. Semiautomated multiplexed quantum dot-based in situ hybridization and spectral deconvolution. J. Mol. Diagn. 2007, 9:20-29.
4. Chan P., Yuen T., Ruf F., Gonzalez-Maeso J., Sealfon S.C. Method for multiplex cellular detection of mRNAs using quantum dot fluorescent in situ hybridization. Nucleic Acids Res. 2005, 33:e161.
5. Chang E.T., Adami H.O. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomark. Prev. 2006, 15:1765-1777.
6. Chen H., Xue J., Zhang Y., Zhu X., Gao J., Yu B. Comparison of quantum dots immunofluorescence histochemistry and conventional immunohistochemistry for the detection of caveolin-1 and PCNA in the lung cancer tissue microarray. J. Mol. Histol. 2009, 40:261-268.
7. Choi Y., Kim H.P., Hong S.M., Ryu J.Y., Han S.J., Song R. In situ visualization of gene expression using polymer-coated quantum-dot-DNA conjugates. Small 2009, 5:2085-2091.
8. Fan S.Q., Ma J., Zhou J., Xiong W., Xiao B.Y., Zhang W.L., Tan C., Li X.L., Shen S.R., Zhou M., Zhang Q.H., Ou Y.J., Zhuo H.D., Fan S., Zhou Y.H., Li G.Y. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum. Pathol. 2006, 37:593-605.
9. Herrmann K., Niedobitek G. Epstein-Barr virus-associated carcinomas: facts and fiction. J. Pathol. 2003, 199:140-145.
10. Hsu W.L., Chen J.Y., Chien Y.C., Liu M.Y., You S.L., Hsu M.M., Yang C.S., Chen C.J. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9, 622 males without family history in Taiwan. Cancer Epidemiol. Biomark. Prev. 2009, 18:1218-1226.
11. Jiang Z., Li R., Todd N.W., Stass S.A., Jiang F. Detecting genomic aberrations by fluorescence in situ hybridization with quantum dots-labeled probes. J. Nanosci. Nanotechnol. 2007, 7:4254-4259.
12. Krishna S.M., James S., Balaram P. Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status. Virus Res. 2006, 115:85-90.
13. Mirzamani N., Salehian P., Farhadi M., Tehran E.A. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization. Exp. Mol. Pathol. 2006, 81:231-234.
14. Müller S., Cremer M., Neusser M., Grasser F., Cremer T. A technical note on quantum dots for multi-color fluorescence in situ hybridization. Cytogenet. Genome Res. 2009, 124:351-359.
15. Nakao K., Mochiki M., Nibu K., Sugasawa M., Uozaki H. Analysis of prognostic factors of nasopharyngeal carcinoma: impact of in situ hybridization for Epstein-Barr virus encoded small RNA 1. Otolaryngol. Head Neck Surg. 2006, 134:639-645.
16. Sam C.K., Brooks L.A., Niedobitek G., Young L.S., Prasad U., Rickinson A.B. Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma. Int. J. Cancer 1993, 53:957-962.
17. Shah K.M., Young L.S. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma. Clin. Microbiol. Infect. 2009, 15:982-988.
18. Speel E.J., Hopman A.H., Komminoth P. Amplification methods to increase the sensitivity of in situ hybridization: play card (S). J. Histochem. Cytochem. 1999, 47:281-288.
19. Tholouli E., Hoyland J.A., Di Vizio D., O'Connell F., Macdermott S.A., Twomey D., Levenson R., Yin J.A., Golub T.R., Loda M., Byers R. Imaging of multiple mRNA targets using quantum dot based in situ hybridization and spectral deconvolution in clinical biopsies. Biochem. Biophys. Res. Commun. 2006, 348:628-636.
20. Tholouli E., Sweeney E., Barrow E., Clay V., Hoyland J.A., Byers R.J. Quantum dots light up pathology. J. Pathol. 2008, 216:275-285.
21. Tsai S.T., Jin Y.T., Mann R.B., Ambinder R.F. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma. Cancer 1998, 82:1449-1453.
22. Xue J., Chen H., Fan M., Zhu F., Diao L., Chen X., Fan L., Li P., Xia D. Use of quantum dots to detect human papillomavirus in oral squamous cell carcinoma. J. Oral Pathol. Med. 2009, 38:668-671.
23. Yao Y., Minter H., Chen X., Reynolds G.M., Bromley M., Arrand J.R. Heterogeneity of HLA and EBER expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int. J. Cancer 2000, 88:949-955.
24. Yip K.W., Shi W., Pintilie M., Martin J.D., Mocanu J.D., Wong D., MacMillan C., Gullane P., O'Sullivan B., Bastianutto C., Liu F.F. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin. Cancer Res. 2006, 12:5726-5732.